FDA approves breakthrough Alzheimer's drug Lecanemab | US news
Drug works with the body’s immune system to clear amyloid protein buildup from the brain
Source: theguardian.com
Stay updated with breaking news from Billy Dunn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drug works with the body’s immune system to clear amyloid protein buildup from the brain
U.S. health officials approved an Alzheimer's drug that could slow cognitive decline in some cases but comes with risks.
US approves new drug to treat Alzheimer's
The new drug, called Leqembi, slowed the rate of cognitive decline in Alzheimer's patients by 27%.
It was granted despite trial results showing the treatment carries risks of brain swelling and bleeding.